Eric R. Olson
2019
In 2019, Eric R. Olson earned a total compensation of $1.6M as Chief Scientific Officer at Syros Pharmaceuticals, a 35% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $195,000 |
|---|---|
| Option Awards | $383,023 |
| Salary | $443,269 |
| Stock Awards | $583,770 |
| Other | $360 |
| Total | $1,605,422 |
Olson received $583.8K in stock awards, accounting for 36% of the total pay in 2019.
Olson also received $195K in non-equity incentive plan, $383K in option awards, $443.3K in salary and $360 in other compensation.
Rankings
In 2019, Eric R. Olson's compensation ranked 7,001st out of 13,971 executives tracked by ExecPay. In other words, Olson earned more than 49.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,001 out of 13,971 | 50th |
Division Manufacturing | 2,682 out of 5,695 | 53rd |
Major group Chemicals And Allied Products | 986 out of 2,194 | 55th |
Industry group Drugs | 835 out of 1,880 | 56th |
Industry Pharmaceutical Preparations | 613 out of 1,392 | 56th |
Source: SEC filing on April 28, 2020.
Olson's colleagues
We found two more compensation records of executives who worked with Eric R. Olson at Syros Pharmaceuticals in 2019.
News
Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
April 23, 2024
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019